文献速递心脑血管急症重症综合管理与镇静镇痛

硬膜下脑电图电极的长期使用与硬膜下血肿:一项前瞻性队列研究

The Long-Term Use of Diagnostic Subdural Electroencephalogram Electrodes and Subdural Hematoma: A Prospective Cohort Study.
PubMed 文献 · Crit Care Med · 2023-08-28
一句话结论急性硬膜下血肿术后患者使用硬膜下条状电极行有创脑电图监测,可更早发现癫痫和癫痫持续状态,并可能改善神经功能预后。

这项前瞻性单中心队列研究纳入76例接受手术治疗的急性硬膜下血肿患者,31例(40.8%)接受硬膜下条状电极有创脑电图监测(可提供长达7天实时记录),45例(59.2%)接受常规表面脑电图。有创监测组癫痫检出率(61% vs 15.6%,P<0.001)和癫痫持续状态检出率(38.7% vs 11.1%,P=0.005)显著更高,检出时间显著更早(癫痫中位29.2 vs 83.8小时,P=0.018;癫痫持续状态中位17.2 vs 83.8小时,P=0.033)。出院时良好预后(GOS 4-5分)比例在有创监测组更高(58% vs 31%,P=0.065),长期死亡率和创伤后癫痫无显著差异。作者认为有创硬膜下脑电图监测对早期发现和治疗癫痫/癫痫持续状态有价值且安全,可能改善预后。

要点

  • 急性硬膜下血肿术后患者中,硬膜下条状电极有创脑电图监测组癫痫检出率61%,常规表面脑电图组15.6%(P<0.001)。
  • 有创监测组癫痫持续状态检出率38.7%,常规组11.1%(P=0.005),检出时间中位17.2 vs 83.8小时(P=0.033)。
  • 有创监测组癫痫检出时间中位29.2小时,常规组83.8小时(P=0.018),提示有创监测可更早启动抗癫痫治疗。
  • 出院时GOS 4-5分比例有创监测组58%,常规组31%(P=0.065),未达统计学显著。
  • 长期死亡率和创伤后癫痫发生率两组无显著差异。

适用人群与场景

  • 接受手术治疗的急性硬膜下血肿患者,来自德国一家学术医院的神经内科和神经外科ICU。
  • 共纳入76例,有创脑电图监测组31例(40.8%),对照组45例(59.2%)。

处置流程与药物剂量

  • 有创脑电图监测组植入硬膜下条状电极,在神经重症监护室提供长达7天的实时脑电图记录。
  • 对照组在7天期间接受常规表面脑电图监测。

研究设计与关键结果

  • 研究类型为前瞻性单中心队列试验,在预设标准达到后经研究委员会会议终止。
  • 两组入院时临床特征匹配良好。
  • 癫痫检出率:有创脑电图组61% vs 对照组15.6%,P<0.001。
  • 癫痫持续状态检出率:有创脑电图组38.7% vs 对照组11.1%,P=0.005。
  • 癫痫检出时间:有创脑电图组中位29.2小时 vs 对照组83.8小时,P=0.018。
  • 癫痫持续状态检出时间:有创脑电图组中位17.2小时 vs 对照组83.8小时,P=0.033。
  • 出院时良好预后(GOS 4-5分):有创脑电图组58% vs 对照组31%,P=0.065。
  • 长期死亡率和创伤后癫痫发生率两组无显著差异。

证据类型、等级与局限

  • 证据类型:前瞻性单中心队列试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,有创硬膜下脑电图监测对急性硬膜下血肿患者早期发现和治疗癫痫/癫痫持续状态有价值且安全,可能改善神经重症监护的预后。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Seizures and status epilepticus (SE) are frequent complications of acute subdural hematoma (aSDH) associated with increased morbidity and mortality. Therefore, we aimed to evaluate whether invasive subdural electroencephalogram recording leads to earlier seizure detection and treatment initiation in patients with aSDH.

DESIGN: Prospective, single-center, cohort trial.

SETTING: Neurologic and neurosurgical ICUs of one academic hospital in Germany.

PATIENTS: Patients with aSDH undergoing surgical treatment. In total, 76 patients were enrolled in this study, 31 patients (40.8%) were assigned to the invasive electroencephalogram (iEEG) monitoring group and 45 patients (59.2%) to control group.

INTERVENTIONS: The electrode group was implanted with a subdural strip electrode providing up to 7 days of real-time electroencephalogram recording in the neurointensive care unit, whereas the control group received regular normal surface electroencephalograms during the 7-day period. The primary outcomes were the prevalence and time to seizures and SE occurrence. Secondary outcomes included neurologic outcomes assessed using the Glasgow Outcome Scale (GOS) at discharge and 6-month follow-up and the prevalence of focal structural epilepsy within 2 years after discharge.

MEASUREMENTS AND MAIN RESULTS: The trial was stopped after a study committee meeting when the prespecified criteria were met. The iEEG and control groups were well-matched for clinical characteristics at admission. Frequencies of seizures and SE detection were significantly higher in the iEEG group than in the control group (61% vs 15.6%; p < 0.001 and 38.7% vs 11.1%; p = 0.005). Time to seizure and SE detection was significantly earlier (median 29.2 vs 83.8 hr; p = 0.018 and 17.2 vs 83.8 hr; p = 0.033) in the iEEG group than in the control group. Favorable outcomes (GOS 4-5) were more frequently achieved in the iEEG group than in the control group (58% vs 31%; p = 0.065). No significant differences were detected in long-term mortality or post-traumatic epilepsy.

CONCLUSIONS: Invasive subdural electroencephalogram monitoring is valuable and safe for early seizure/SE detection and treatment and might improve outcomes in the neurocritical care of patients with aSDH.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Won SY, Freiman TM, Lee-Müller SS, et al. The Long-Term Use of Diagnostic Subdural Electroencephalogram Electrodes and Subdural Hematoma: A Prospective Cohort Study. Crit Care Med. 2023. PMID: 37638780. doi:10.1097/CCM.0000000000006033

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。